Winningham Rick E
CHIEF EXECUTIVE OFFICER
Winningham Rick E has filed 10 SEC Form 4 filings (18 transaction rows) across 2 companies, including TBPH, JAZZ, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.
On the most recent filing, Winningham Rick E is listed as Director at Jazz Pharmaceuticals plc. Inside the rolling window, Winningham Rick E reported no open-market purchases and 2 open-market sales totaling $1.7M in JAZZ. The largest disclosed transaction in the window is a sale of 5,500 JAZZ shares on Nov 18, 2025, worth $995K.
Companies traded
Other insiders at TBPH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Winningham Rick E made?
Winningham Rick E has filed 10 SEC Form 4 filings (18 transaction rows) across 2 companies, including TBPH, JAZZ since 2025.
Which companies does Winningham Rick E trade?
Winningham Rick E has filed SEC Form 4 disclosures for 2 companies, including TBPH, JAZZ.
When was Winningham Rick E's most recent SEC Form 4 filing?
Winningham Rick E's most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.
What is Winningham Rick E's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Winningham Rick E is listed as CHIEF EXECUTIVE OFFICER.
What is Winningham Rick E's total buy and sell value in the current window?
Inside the rolling retention window, Winningham Rick E bought $0 and sold $1.7M based on SEC Form 4 filings.
What was Winningham Rick E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,500 JAZZ shares on 2025-11-18, worth $995K, per SEC Form 4 filings.